The platelet aggregation inhibitor ticagrelor, a P2Y receptor antagonist, is widely used after angioplasty in patients with acute coronary syndrome. Clinical trial data have shown that it is well tolerated by most patients. We present the case of a 62-year-old woman whose ticagrelor-related asymptomatic and persistent sinus pauses after angioplasty resolved when ticagrelor was replaced with prasugrel.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827480 | PMC |
| http://dx.doi.org/10.14503/THIJ-17-6554 | DOI Listing |
Publication Analysis
Top Keywords
62-year-old woman
8
acute coronary
8
coronary syndrome
8
sinoatrial arrest
4
arrest caused
4
caused ticagrelor
4
ticagrelor angioplasty
4
angioplasty 62-year-old
4
woman acute
4
syndrome platelet
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!